Krotex Pharmsp. z o.o. + limited partnership

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-11-30
Limited partner contribution
5,200.00 PLN
Registered address
Szczęsna 26, 02-454 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 111 days for 2022). 1 of 5 audited by a statutory auditor.

  • 2023not filed
  • 202203/11/2023
  • 202102/08/2022
  • 202017/06/2021
  • 201906/08/2020
  • 201804/06/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Industry · Manufacture of pharmaceutical preparations136 / 258
Top 53%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations154 / 330
Top 47%
Sector · Manufacturing16,244 / 33,759
Top 48%
Voivodeship · Mazowieckie38,223 / 142,058
Top 27%
Country · Poland140,080 / 495,976
Top 28%

Results vs industry

Revenue
This companyUSD 697.72kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -458.79kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 1.04mMedianUSD 873.06kAverageUSD 21.42m
Assets
This companyUSD 1.01mMedianUSD 897.46kAverageUSD 31.52m

Industry

Trademarks

Krotex Pharm holds 8 active trademarks registered with the Polish Patent Office. 20 marks have expired or were not registered. The first mark was filed in 1995.

MarkNumberClassesStatusProtected until
Aquamer(word)Z.5290035Protected May 18, 2031
KROTEXZ.4710085, 10, 29, 30Protected Apr 27, 2027
CHITININ EXTRA(word)Z.3495315Protected Dec 5, 2028
uretin żurawinaZ.3457855Protected Sep 5, 2028
CHITININ(word)Z.3436485Protected Jul 16, 2028
MarkProtected until
Aquamer(word)May 18, 2031
KROTEXApr 27, 2027
CHITININ EXTRA(word)Dec 5, 2028
uretin żurawinaSep 5, 2028
CHITININ(word)Jul 16, 2028

Authorized Representatives

Maksymilian Benedykt Jaromskiage 33 – Attorney-in-fact (sole)

Manner of representation

Each general partner represents the company independently.

Partners

Partners
Wiktoria Elżbieta Jaromska-Gumkowskaage 37
Maksymilian Benedykt Jaromskiage 33
Krotex Pharm sp. z o.o.
Elżbieta Helena Murawskaage 88

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-03-19.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

21 public aid cases recorded, with a total value of $379,986.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

Competitors

Name
VitamaS.A.
Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o.
Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o.
Biomarsp. z o.o.
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.
Human BiomeS.A.
Zeptor Polskasp. z o.o.
DR Andresp. z o.o.
Stem Cells SpinS.A.
F1 PharmaS.A.

Change history

DateEvent
2026-09-10Address change
2015-03-11PKD change
2014-06-10PKD change
2013-04-25Name change
2012-11-30Entered in the register

FAQ

Last updated: 2026-10-02